Literature DB >> 3664929

Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites.

G J Peters1, C J van Groeningen, E J Laurensse, J Lankelma, A Leyva, H M Pinedo.   

Abstract

Administration of high-dose uridine or cytidine (3500 mg/kg) resulted in severe hypothermia of 6-10 degrees C in mice. This effect of uridine was observed in three different mouse strains, C57B1/6, Balb/c, and Swiss. A high-dose of uridine also caused hypothermia in Wistar rats. Co-infusion of uridine with benzylacyclouridine, an inhibitor of uridine phosphorylase, partially prevented uridine-mediated hypothermia in mice. A low dose of uridine (100 mg/kg) resulted in a slight increase in temperature. Plasma pharmacokinetics of uridine (at 3500 mg/kg) were studied in two mouse strains, C57B1/6 and Balb/c, and those of cytidine only in C57B1/6 mice. Peak plasma concentrations of uridine in both strains after uridine administration were about 20 mM (at 30-60 min). The peak plasma concentration of cytidine in C57B1/6 mice after cytidine administration was about 12 mM and that of uridine, 1.3 mM. The mean residence time for uridine was about 105 min. The area under the plasma concentration-time curve for uridine was about 50 mmol h/l, and that for cytidine, about 25 mmol h/l. In various tissues of C57B1/6 mice the levels of uridine, uracil and total uracil and cytosine nucleotide pools were determined before and 2 h after uridine administration. Uridine levels increased about 53-fold in liver, about 70-fold in a colon tumor, and only about 7-fold in brain, while the corresponding uracil levels increased about 9-fold, 4-fold and 11-fold, respectively. Total uracil nucleotide pools increased about 8-fold, 3.2-fold and 1.6-fold, respectively. Cytosine nucleotide pools did not increase in the brain. In conclusion, high-dose uridine administration caused severe hypothermia. Plasma levels of uridine and uracil were enhanced to a considerably higher extent than the levels in the tissues. The hypothermia might be related to breakdown products of uridine, since inhibition of uridine breakdown partially prevented hypothermia and since in brain uracil nucleotide levels were only slightly increased after uridine administration, while those of uracil were more markedly increased than in other tissues.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3664929     DOI: 10.1007/bf00253962

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  41 in total

1.  Pyrimidine metabolism in lymphocytes and erythrocytes of man, horse and cattle.

Authors:  W J Tax; G J Peters; J H Veerkamp
Journal:  Int J Biochem       Date:  1979

2.  Tissue uridine pools: evidence in vivo of a concentrative mechanism for uridine uptake.

Authors:  J W Darnowski; R E Handschumacher
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

3.  Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.

Authors:  J D Moyer; R E Handschumacher
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

Review 4.  Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines.

Authors:  J W Daly; R F Bruns; S H Snyder
Journal:  Life Sci       Date:  1981-05-11       Impact factor: 5.037

5.  Toxicologic effects of a high dose of thymidine in mice.

Authors:  E H Herman; W Jordan; B Ardalan; D S Zaharko; B J Bolten; D A Cooney
Journal:  Toxicol Appl Pharmacol       Date:  1980-12       Impact factor: 4.219

6.  Effects of adenosine and two stable adenosine analogues on blood pressure, heart rate and colonic temperature in the rat.

Authors:  B Jonzon; A Bergquist; Y O Li; B B Fredholm
Journal:  Acta Physiol Scand       Date:  1986-04

7.  Thymidine and thymine in biologic fluids during high-dose infusions of thymidine in mice, monkeys, and man.

Authors:  D S Zaharko; B J Bolten; T Kobayashi; R G Blasberg; S S Lee; B C Giovanella; J S Stehlin
Journal:  Cancer Treat Rep       Date:  1979-06

8.  Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.

Authors:  D S Zaharko; L M Ramonas
Journal:  J Natl Cancer Inst       Date:  1982-05       Impact factor: 13.506

9.  Protective effect of uridine on D-galactosamine-induced deficiency in brain uridine phosphates.

Authors:  N Popov; S Schmidt; H Matthies
Journal:  Biomed Biochim Acta       Date:  1984

10.  Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.

Authors:  G J Peters; E Laurensse; A Leyva; J Lankelma; H M Pinedo
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

View more
  18 in total

Review 1.  Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides.

Authors:  R J Wurtman; M Cansev; I H Ulus
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

Review 2.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

3.  Characterization of basal and morphine-induced uridine release in the striatum: an in vivo microdialysis study in mice.

Authors:  Wu Song; Chun-Fu Wu; Ping Liu; Rong-Wu Xiang; Fang Wang; Ying-Xu Dong; Jing-Yu Yang
Journal:  Neurochem Res       Date:  2012-10-16       Impact factor: 3.996

4.  Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice.

Authors:  Jan H Beumer; Julie L Eiseman; Robert A Parise; Jeffry A Florian; Erin Joseph; David Z D'Argenio; Robert S Parker; Brittany Kay; Joseph M Covey; Merrill J Egorin
Journal:  Cancer Chemother Pharmacol       Date:  2007-11-15       Impact factor: 3.333

5.  Nucleoside map of the human central nervous system.

Authors:  Zsolt Kovács; Arpád Dobolyi; Gábor Juhász; Katalin A Kékesi
Journal:  Neurochem Res       Date:  2009-10-24       Impact factor: 3.996

Review 6.  Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses.

Authors:  Mehmet Cansev; Richard J Wurtman; Toshimasa Sakamoto; Ismail H Ulus
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

7.  Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma.

Authors:  G J Peters; J Lankelma; R M Kok; P Noordhuis; C J van Groeningen; C L van der Wilt; S Meyer; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

8.  Effects of 5-benzylacyclouridine, an inhibitor of uridine phosphorylase, on the pharmacokinetics of uridine in rhesus monkeys: implications for chemotherapy.

Authors:  J P Sommadossi; E M Cretton; L B Kidd; H M McClure; D C Anderson; M H el Kouni
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Biochemical consequences of 5-fluorouracil gastrointestinal toxicity in rats; effect of high-dose uridine.

Authors:  J Kralovanszky; N Prajda; S Kerpel-Fronius; T Bagrij; E Kiss; G J Peters
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

10.  Schedule-dependency of in vivo modulation of 5-fluorouracil by leucovorin and uridine in murine colon carcinoma.

Authors:  J C Nadal; C J van Groeningen; H M Pinedo; G J Peters
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.